Interns continue to make tough choices

Published Date: 02 Mar 2023

The Medscape Ethics Survey investigated how internal medicine physicians view the ethical aspects of the response to medical assistance in dying, gender-related publications and materials.

Read Full News

Latest News

Lost in Translation: Cancer Care's Coordination Problem

No shared records. No standard handoff. No common language. Three physicians break down why cancer care coordination keeps failing.

S3 Episode 5: The Future of Endometrial Cancer Pathology

Drs Ursula A. Matulonis and Marisa R. Nucci discuss the future of AI and pathology and how genetics and genomics play a role in the diagnosis of endometrial cancer.

What ASCO 2026 Taught Us About Scaling AI in Cancer Care

The next era of oncology AI won’t be won by the best model, the highest benchmarks, or flashiest press release. It will be won by the most reliable pathway to deployability.

Practice-Changing Data in GI Oncology

From ASCO 2026, Dr Mark Lewis breaks down a 'transformational' shift in GI oncology, from the historic RAS revolution to biomarker-driven advances in colon cancer.

S1 Episode 1: Can Primary Care Catch MASLD Before Cirrhosis?

MASLD is a silent condition and labs may look normal. Drs VanWagner and Shubrook walk through who to screen, how to use FIB-4, and when primary care can manage MASLD without a specialist.

S1 Episode 2: Recurrent UTIs in Older Women

Drs Anne Lenore Ackerman and Melissa Kaufman discuss recurrent UTIs in older women and its association with genitourinary syndrome of menopause.

Todays Updates

PPI, Antibiotics May Curb Durvalumab Efficacy in NSCLC

Study adds to evidence that the widely used medications may interfere with immunotherapy efficacy via effects on the gut microbiome.

FDA Approves Subcutaneous Isatuximab for MM Indications

The drug can now be administered with the hands-free automated CirCLIQ on-body injector.

Todays Updates

PPI, Antibiotics May Curb Durvalumab Efficacy in NSCLC

Study adds to evidence that the widely used medications may interfere with immunotherapy efficacy via effects on the gut microbiome.

FDA Approves Subcutaneous Isatuximab for MM Indications

The drug can now be administered with the hands-free automated CirCLIQ on-body injector.

Latest News

No shared records. No standard handoff. No common language. Three physicians break down why cancer care coordination keeps failing.

Drs Ursula A. Matulonis and Marisa R. Nucci discuss the future of AI and pathology and how genetics and genomics play a role in the diagnosis of endometrial cancer.

The next era of oncology AI won’t be won by the best model, the highest benchmarks, or flashiest press release. It will be won by the most reliable pathway to deployability.

From ASCO 2026, Dr Mark Lewis breaks down a 'transformational' shift in GI oncology, from the historic RAS revolution to biomarker-driven advances in colon cancer.

MASLD is a silent condition and labs may look normal. Drs VanWagner and Shubrook walk through who to screen, how to use FIB-4, and when primary care can manage MASLD without a specialist.

Drs Anne Lenore Ackerman and Melissa Kaufman discuss recurrent UTIs in older women and its association with genitourinary syndrome of menopause.

News All Time

A Child With a Nontender, Nonbleeding Papule on Her Thigh

A 14-month-old female with a history of atopy presented with an 8-month history of a persistent, non-tender, non-bleeding cutaneous papule with an erythematous rim on the left thigh.

Is Alcohol Part of a Healthy Lifestyle?

Cardiologist Chris Labos takes a look at the French paradox and the J-shaped curve — which tout moderate alcohol as healthy — and asks is the amount of alcohol you should drink really zero?

S3 Episode 4: Investigator-Initiated Clinical Trials in Endometrial Cancer

Drs Ursula A. Matulonis and Stephanie Lheureux discuss the importance of investigator-initiated clinical trials in endometrial cancer, research on carcinosarcoma, and ctDNA.

Biomarkers for Cardiovascular Drug Development

A proposal for a context-of-use framework in which circulating biomarkers are assessed along 2 converging “evidence lanes”: analytical readiness and clinical or statistical validation.

T2* MRI Maps Iron in Finger Soft Tissue in Microvasculopathy

Quantitative T2* MRI is feasible and reproducible for detecting microvasculopathy-related iron deposition in the soft tissues of the fingers.

S4 Episode 4: How Confident Should We Be in Psoriasis Biosimilars?

Join Drs Steven Feldman and Jonathan Kay as they examine the data on safety, switching, and confidence in psoriasis biosimilars.

10 Medical Breakthroughs Transforming Clinical Care

CRISPR cures for sickle cell disease, gene therapy for hemophilia A, and expanding CAR T cell uses point to a new era of potentially curative, personalized treatments.

Imaging and Staging Essentials in Uveal Melanoma

Dr Teresa Amaral reviews new uveal melanoma guidelines, focusing on AJCC 8th Edition staging, the Liverpool prognostic tool, and the essential role of BAP1 and PRAME expression.

Vaccinated Woman With COVID Rebound After Ensitrelvir

A possible first case of COVID recurrence after ensitrelvir: a vaccinated woman whose antigen levels fall and then rebound, with symptoms returning 1 day after treatment.

Optimizing UC Therapy in the Presence of Comorbidities

Dr Corey Siegel discusses the importance of individualized therapy selection for ulcerative colitis in the presence of comorbidities.

ESMO Update: New Guidance for Rare Uveal Melanoma

Dr Teresa Amaral breaks down the essential new guidelines for uveal melanoma. Stay ahead of the latest standards in patient care.

A New Ultrapotent Opioid Emerges: What Is Cychlorphine?

Dr Robert Glatter speaks with toxicologist Dr Lewis Nelson about cychlorphine, a newly emerging synthetic opioid linked to fatal overdoses, and what clinicians should understand about detection, naloxone response, and the evolving drug landscape.

Soccer ‘Headers’ Acutely Raise Brain Damage Biomarkers

Study findings are concerning, but will the world’s most popular sport ban the practice of heading the ball?

Lipid Guidelines: Four Major Concerns

Too many Class I recommendations lacking supporting data from randomized trials and intellectual conflicts of interest are among John Mandrola’s complaints about the ACC/AHA guidelines on dyslipidemia.

Canadian EHR Interoperability Weak, Uneven, Harming Patients

Most Canadian physicians use electronic health records, but a lack of connectivity means that patient health information remains siloed across different software programs.

Angiolipoleiomyoma Masquerading as Leiomyoma in a Woman

A 45-year-old woman with a 2-year vaginal foreign body sensation and constipation has a large posterior vaginal wall mass; a biopsy suggests leiomyoma, but excision reveals angiolipoleiomyoma.

Recommended News For You

Both DNA damage repair deficiency and non-Hodgkin lymphoma are the focus of LP-284.

Antitumor cell activity in glioblastoma is controlled by blocking the triggering receptor expressed on myeloid cells 2.

Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey

Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypes

Top FDA Official Exits; SCOTUS Takes Up Obamacare Case; Texas Doc Suspended

Browse the NBE-Released Curriculum at FNB Head and Neck Oncology.

EMA OKs Two Treatments for Small Cell Lung Cancer

Recommended Articles For You

How is Digital Innovation Revolutionizing Gynecologic Oncology Treatment and Patient Engagement? 

Everything You Need to Know About Normal Potassium Levels  

Immuno-Oncology in Daily Practice: Transforming Cancer Care One Patient at a Time 

Surprising Symptoms of Prostate Cancer: What You Need to Know 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Beyond What Is Visible in Myelofibrosis?

2.

The risk of cancer is decreased by following international health recommendations.

3.

Chemotherapy can be a challenging treatment?here's how to deal with some of the side-effects

4.

Cancer Patients' Depression May Be Helped by Psilocybin.

5.

Basal stem-like cells identified as origin of small cell lung cancer in lab models

1.

Precision Risk Interception in Oncology: A Comprehensive Review

2.

Critical Care Challenges in Oncologic Emergencies

3.

Understanding Pomalidomide: A promising drug for multiple myeloma treatment

4.

Ear Emergency: Understanding the Causes and Treatment for Auricular Hematoma

5.

Essential Concepts in Oncology for Better Care

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2

2.

Efficient Management of First line ALK-rearranged NSCLC - Part VI

3.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot